ArticleEuropean journal of neurology2022

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real-world evidence.

Modar Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.